Alumis, Inc. (ALMS)
25.50
-0.62
(-2.39%)
USD |
NASDAQ |
May 06, 16:00
25.50
0.00 (0.00%)
After-Hours: 16:07
Alumis Total Assets (Quarterly) : 416.14M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 86.48B |
| Nektar Therapeutics | 280.41M |
| Oramed Pharmaceuticals, Inc. | 230.86M |
| Aclaris Therapeutics, Inc. | 160.46M |
| Crinetics Pharmaceuticals, Inc. | 1.135B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 114.84M |
| Shareholders Equity (Quarterly) | 301.30M |
| Debt to Equity Ratio | 0.1225 |
| Current Ratio | 4.340 |
| Net Debt Paydown Yield | -0.11% |